Lupin targets buys in Gulf, Mexico, Brazil and Argentina

23 Oct 2009 Evaluate

The Rs 3,866 crore pharma major Lupin Ltd is likely to go in for overseas acquisitions within 6 to 9 months. Lupin is negotiating with a few companies in Gulf, Mexico, Brazil and Argentina, as it intends to increase its footprint in newer markets. The acquisition would be of companies involved in pharma marketing or those who have a mix of marketing and manufacturing base.

The Mumbai-based company has been on a buying spree. It acquired a company, Kyowa, in Japan in 2007, followed by a Pharma Dynamics’ buy in South Africa in 2008 and the latest acquisition of Multicare Pharmaceutical in Philippines, earlier this year.

Lupin chairman Desh Bandhu Gupta hinted last year that the company was eyeing acquisitions in Middle East and Latin America to bolster its presence in this market. Now, the plan has taken a concrete shape, with recessionary sentiment waning in the overseas markets. crackcrack

Lupin Share Price

1653.75 -8.05 (-0.48%)
17-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.